Despite widespread reports last month that a drug approved to fight osteoporosis also decreases the risk of breast cancer among post-menopausal women, a federal judge has enjoined the drug's manufacturer from promoting the drug as protecting against cancer. U.S. District Judge John G. Koeltl, in Zeneca Inc. v. Eli Lilly and Co., last Thursday granted a preliminary injunction against drug maker Eli Lilly and Co.
July 20, 1999 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Despite widespread reports last month that a drug approved to fight osteoporosis also decreases the risk of breast cancer among post-menopausal women, a federal judge has enjoined the drug’s manufacturer from promoting the drug as protecting against cancer.
U.S. District Judge John G. Koeltl in Zeneca Inc. v. Eli Lilly and Co., 99-Civ.-1452 (QDS:02310323), last Thursday granted a preliminary injunction against drug maker Eli Lilly and Co.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
